VirusArchives
Serological evidence of concurrent Lassa virus and SARS-CoV-2 exposure in Ghana- a cross-sectional study
Virus 5 min.
The emergence and rapid global spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), responsible for the COVID-19 pandemic, exposed the vulnerabilities in existing healthcare surveillance systems, particularly in low-and-middle income countries [1, 2]. As of May 2025, a report by the...
Trajectories of health-related quality of life among people with HIV within five years of diagnosis
Virus 5 min.
By the end of 2024, an estimated 1.35 million individuals in China were living with human immunodeficiency virus (HIV), highlighting its status as a major public health concern [1]. Since the launch and expansion of the National Free Antiretroviral Treatment Program in 2002, access to antiretroviral...
K5 polysaccharides inhibit SARS-CoV-2 infection by preventing spike-proteolytic priming
Virus 11 min.
Since 2020, the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has heavily affected the lives of people all around the world. Despite the development of efficacious vaccines, surveillance systems, and personal protective equipment reducing the spread of infection,...
Hybrid, infection- and vaccination-induced protection against laboratory- confirmed SARS-CoV-2 infection in a European multi-centre prospective cohort of healthcare workers, 2021–2024
Virus 6 min.
Vaccination against the coronavirus disease 2019 (COVID-19) and natural infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can each induce immunological protection against SARS-CoV-2 infection. The combined protection is known as hybrid immunity. High incidence of SARS-CoV-2...
